Showing results (21-30 of 237) with videos related to
Sort By:
Pageof 24
Human Molecular Genetics|October 5, 2017
Spinal muscular atrophy: antisense oligonucleotide therapy opens the door to an integrated therapeutic landscapeMatthew J A Wood, Kevin Talbot, Melissa BowermanJournal of Neurology, Neurosurgery, and Psychiatry|September 14, 2021
Higher blood high density lipoprotein and apolipoprotein A1 levels are associated with reduced risk of developing amyotrophic lateral sclerosisAlexander G Thompson, Kevin Talbot, Martin R TurnerDisease Models & Mechanisms|June 29, 2011
The contribution of mouse models to understanding the pathogenesis of spinal muscular atrophyJames N Sleigh, Thomas H Gillingwater, Kevin TalbotExpert Reviews in Molecular Medicine|July 21, 2010
The role of RNA processing in the pathogenesis of motor neuron degenerationDirk Bäumer, Olaf Ansorge, Mara Almeida, et al.Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|May 7, 2024
Recent insights from human induced pluripotent stem cell models into the role of microglia in amyotrophic lateral sclerosisLara M Nikel, Kevin Talbot, Björn F VahsenTrends in Neurosciences|February 16, 2010
GARS axonopathy: not every neuron's cup of tRNAWilliam W Motley, Kevin Talbot, Kenneth H FischbeckThe Journal of Gene Medicine|July 7, 2010
The ARRIVE guidelines, a welcome improvement to standards for reporting animal researchOlivier Danos, Kay Davies, Pierre Lehn, et al.Brain Research|November 3, 2007
Knockdown of SMN by RNA interference induces apoptosis in differentiated P19 neural stem cellsBarbara Trülzsch, Catherine Garnett, Kay Davies, et al.Toxins|October 24, 2020
Neurotrophic Properties of C-Terminal Domain of the Heavy Chain of Tetanus Toxin on Motor Neuron DiseaseMireia Herrando-Grabulosa, Caty Casas, Kevin Talbot, et al.Nature Reviews. Neurology|February 10, 2018
Advances in therapy for spinal muscular atrophy: promises and challengesEwout J N Groen, Kevin Talbot, Thomas H GillingwaterPageof 24